Tevogen Bio Holdings Inc. ("Tevogen" or "Tevogen Bio") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology,
The wealth of Nvidia CEO Jensen Huang has soared in 2024 alongside Nvidia stock hitting new all-time highs. Could Huang become one of the 10 richest people in the world?
FDA rescinds marketing denial orders for JUUL Labs Inc., pending further review. Recent case law influences decision. FDA seeks scientific soundness in e-cigarette approval process. JUUL's financial woes continue amid regulatory uncertainty.
Lululemon Athletica beat first-quarter expectations, leading to positive analyst reactions. BofA Securities raised the price target to $440, highlighting strong sales growth and robust international performance. Wedbush noted potential for domestic improvement through innovation. J.P. Morgan emphasized LULU's international growth and e-commerce expansion. Telsey Advisory Group acknowledged improved inventory and innovation as key to overcoming domestic challenges.